Skip to main content
Skip to content
Case File
efta-efta01521223DOJ Data Set 10Correspondence

EFTA Document EFTA01521223

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01521223
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
CHISLAINE MAXWELL ACCT. For the Period 5/1/12 to Equity Summary Asset Categories US Large Cap Equity 58320.07 55.459.33 (2.860.74) 1% US Small/Mid Cap Equity 5.025.00 3.930.00 (1.095.00) 1% Non-US Equity 167.22 128.37 (38.85) 1% Preferred Stocks 431,244.00 428865 00 (2.379.00) 5% Concentrated 8 Other Equity 203.386.00 199389.00 (3.997.00) 2% Total Value $898,142.29 $887,771.70 ($10,370.59) 10% Beginning Market Value Ending Market Value Change Current Asset Categories In Value Allocation NI a diet Value/Cost Current Period Value Market Vane 687,771.70 Tax Cost 764,967.39 Unrealized Gain LCGS (77,195.69) Estimated Annual Income 45,693.48 Accrued Di lends 1.65457 Yield 6.63% Equity Detail Non-US EQuaY US SmalaMal Cap Equity US Largo Cap Equity Equity as a percentage of your portfolio - 10 % Pretend Stocks Concentrated a Omar Epupy Price Quantity Value Adjusted Tax Cost Original Cost Unrealized Est. Annual Inc. Gain/Loss Accrued Div. Yield US Large Cap Equity APACHE CORP 037411-10-5 APA J.P.Morgan 81.38 95.000 7.731 10 11.403 30 (3.672 20) 64.60 0.84% Page 4 of 29 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048589 SDNY_GM_00317787 EFTA01521223

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.